[{"NetIncomeLoss_1_Q3_USD":2657000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":1000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":19358000.0,"InterestPaidNet_3_Q3_USD":1443000.0,"InventoryFinishedGoods_0_Q3_USD":289000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":1764000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":23248000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-563000.0,"AssetsCurrent_0_Q3_USD":203932000.0,"DerivativeGainLossOnDerivativeNet_3_Q3_USD":62249000.0,"DerivativeGainLossOnDerivativeNet_1_Q3_USD":23837000.0,"DilutiveSecurities_3_Q3_USD":-62249000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8077000.0,"DilutiveSecurities_1_Q3_USD":-23837000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":3298000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":1310000.0,"SellingAndMarketingExpense_3_Q3_USD":26054000.0,"SellingAndMarketingExpense_1_Q3_USD":9576000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":10948312.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":3226777.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":678000.0,"ConvertibleDebtNoncurrent_0_Q3_USD":25886000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"CommonStockSharesIssued_0_Q3_shares":76606968.0,"Assets_0_Q3_USD":217739000.0,"ShareBasedCompensation_3_Q3_USD":11136000.0,"DebtInstrumentUnamortizedDiscount_0_Q3_USD":118000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":24345000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"Liabilities_0_Q3_USD":130399000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1387000.0,"IncomeTaxExaminationPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":37505000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":12719000.0,"InventoryRawMaterials_0_Q3_USD":370000.0,"EarningsPerShareBasic_3_Q3_USD":-0.04,"EarningsPerShareBasic_1_Q3_USD":0.03,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":82086795.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":85446886.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":3529000.0,"AccountsReceivableNetCurrent_0_Q3_USD":19552000.0,"CommonStockValue_0_Q3_USD":8000.0,"LongTermNotesPayable_0_Q3_USD":24936000.0,"InvestmentIncomeNet_3_Q3_USD":27000.0,"InvestmentIncomeNet_1_Q3_USD":7000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":1851000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":2184000.0,"CostsAndExpenses_3_Q3_USD":91202000.0,"CostsAndExpenses_1_Q3_USD":31682000.0,"ProceedsFromNotesPayable_3_Q3_USD":3722000.0,"IncreaseDecreaseInInventories_3_Q3_USD":21000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-2703000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":2657000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1430000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":179281000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":6355000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":629286000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5129000.0,"InterestOnConvertibleDebtNetOfTax_1_Q3_USD":1113000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"RepaymentsOfNotesPayable_3_Q3_USD":4167000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3758000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-50397000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":76317563.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":76552060.0,"InventoryWorkInProcess_0_Q3_USD":563000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_3_Q3_shares":5769232.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q3_shares":5769232.0,"LiabilitiesCurrent_0_Q3_USD":25158000.0,"AccountsPayableCurrent_0_Q3_USD":4246000.0,"NonoperatingIncomeExpense_3_Q3_USD":57285000.0,"NonoperatingIncomeExpense_1_Q3_USD":22186000.0,"InterestExpense_3_Q3_USD":4991000.0,"AmortizationOfFinancingCosts_3_Q3_USD":3440000.0,"InterestExpense_1_Q3_USD":1658000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":490000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3877000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2414000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1034000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":3125594.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-61666000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-20067000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q3_USD":25000000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":199000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6914000.0,"NetIncomeLoss_3_Q3_USD":-2703000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":181045000.0,"IncreaseDecreaseInDerivativeLiabilities_3_Q3_USD":62249000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.23,"EarningsPerShareDiluted_3_Q3_USD":-0.75,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"NotesPayable_0_Q3_USD":24936000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-773000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":31214000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":12153000.0,"OperatingIncomeLoss_3_Q3_USD":-59988000.0,"OperatingIncomeLoss_1_Q3_USD":-19529000.0,"InventoryNet_0_Q3_USD":1222000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":217739000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6757000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"DerivativeLiabilities_0_Q3_USD":36064000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":11136000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3758000.0,"DerivativeLiabilitiesNoncurrent_0_Q3_USD":36064000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1554000.0,"ProfitLoss_3_Q3_USD":-2703000.0,"StockholdersEquity_0_Q3_USD":87340000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":12000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":563000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":25000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-541954000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-48776000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":7300000.0,"CommonStockSharesOutstanding_0_Q3_shares":76606968.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":-275000.0,"InterestOnConvertibleDebtNetOfTax_3_Q3_USD":3286000.0,"Ticker":"OCUL","CIK":"1393434","name":"OCULAR THERAPEUTIX, INC","OfficialName":"Ocular Therapeutix Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"305481557.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]